Cargando…
Implementing personalized medicine with asymmetric information on prevalence rates
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare sys...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990530/ https://www.ncbi.nlm.nih.gov/pubmed/27539222 http://dx.doi.org/10.1186/s13561-016-0113-7 |